Lantheus Holdings Inc. (LNTH) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Lantheus Holdings Inc., updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$100.10
−0.05% today
Market cap
$6.5B
Overall quality
—
Kronos AI 30-day
−0.9%
2 of 8 simulated paths end higher
Lantheus Holdings Inc. (LNTH) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $6.5B. It trades at $100.10, down 0.05% today. 8 analysts' average target of $104.38 implies +4.3% from today's price. Kronos AI's 30-day forecast is −0.9% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $104.38 |
| Low – high | $102.50 – $109.00 |
| Analysts | 8 |
| Upside to average | +4.3% |
Kronos AI 30-day forecast
| Expected close | $99.29 (−0.9%) |
| Likely range | −1.3% … +3.0% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.